Class IIOngoing

Losartan Potassium and Hydrochlorothiazide Tablets recall

FDA recall D-0498-2024 · initiated May 7, 2024

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of foreign substance: plastic-like substance.

Details

Product: Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-050-44
Recalling company: Macleods Pharms Ltd
Classification: Class II
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: USA Nationwide
Initiated: May 7, 2024
FDA report date: May 22, 2024

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0498-2024 ↗

← All drug recalls